Skip to main content
. 2024 Mar 30;10(7):e28941. doi: 10.1016/j.heliyon.2024.e28941

Fig. 2.

Fig. 2

Standardised prevalence (95% confidence intervals) of the 5 symptoms at T3 that were significantly elevated (p.BH < 0,05) between Omicron cases and both control groups and their prevalence in Delta cases using complete case analysis without substituting for missing values at T3. Symptoms are ranked by prevalence in Omicron cases. *BH.adjusted p-value < 0.05; **BH.adjusted p-value < 0.01; ***BH.adjusted p-value < 0.001 compared to Omicron cases. Symptoms are self-reported and quantified according to the mean standardized prevalence.